BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
6.43
-0.39 (-5.72%)
At close: Jul 3, 2025, 1:00 PM
6.38
-0.05 (-0.78%)
After-hours: Jul 3, 2025, 4:59 PM EDT
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $11.55 million as of July 3, 2025. Its market cap has increased by 45.30% in one year.
Market Cap
11.55M
Enterprise Value
8.17M
1-Year Change
45.30%
Ranking
Category
Stock Price
$6.43
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $11.55M, a decrease of -72.57%. That is a compound annual growth rate of -23.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 11.55M | 129.87% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 223.87B |
| BHP Group | 128.77B |
| Rio Tinto Group | 100.44B |
| The Sherwin-Williams Company | 88.53B |
| Southern Copper | 85.12B |
| Ecolab | 77.71B |
| Newmont | 65.95B |
| Freeport-McMoRan | 65.78B |